188 related articles for article (PubMed ID: 35276465)
21. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
[TBL] [Abstract][Full Text] [Related]
22. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study.
Wang WP; Liu N; Kang Q; Du PP; Lan Y; Zhao BC; Chen YY; Zhang Q; Li H; Zhang YW; Wu Q
J Zhejiang Univ Sci B; 2014 Nov; 15(11):929-39. PubMed ID: 25367786
[TBL] [Abstract][Full Text] [Related]
24. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
[TBL] [Abstract][Full Text] [Related]
25. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion.
Liebgott T; Miollan M; Berchadsky Y; Drieu K; Culcasi M; Pietri S
Basic Res Cardiol; 2000 Oct; 95(5):368-77. PubMed ID: 11099163
[TBL] [Abstract][Full Text] [Related]
26. Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Iwamoto K; Kawamoto H; Takeshita F; Matsumura S; Ayaki I; Moriyama T; Zaima N
J Oleo Sci; 2019 Sep; 68(9):923-930. PubMed ID: 31413248
[TBL] [Abstract][Full Text] [Related]
27. Induction of cytochrome P450 3A by the Ginkgo biloba extract and bilobalides in human and rat primary hepatocytes.
Deng Y; Bi HC; Zhao LZ; Wang XD; Chen J; Ou ZM; Ding L; Xu LJ; Guan S; Chen X; Zhou SF; Huang M
Drug Metab Lett; 2008 Jan; 2(1):60-6. PubMed ID: 19356072
[TBL] [Abstract][Full Text] [Related]
28. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
Smith PF; Maclennan K; Darlington CL
J Ethnopharmacol; 1996 Mar; 50(3):131-9. PubMed ID: 8691847
[TBL] [Abstract][Full Text] [Related]
29. Interaction between ticlopidine or warfarin or cardioaspirin with a highly standardized deterpened Ginkgo biloba extract (VR456) in rat and human.
Di Pierro F; Rinaldi F; Lucarelli M; Rossoni G
Acta Biomed; 2010 Dec; 81(3):196-203. PubMed ID: 22530457
[TBL] [Abstract][Full Text] [Related]
30. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
31. GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides.
Ng CC; Duke RK; Hinton T; Johnston GA
Eur J Pharmacol; 2016 Apr; 777():136-46. PubMed ID: 26953225
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen-glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model.
Yang X; Zheng T; Hong H; Cai N; Zhou X; Sun C; Wu L; Liu S; Zhao Y; Zhu L; Fan M; Zhou X; Jin F
Front Med; 2018 Jun; 12(3):307-318. PubMed ID: 29058254
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
[TBL] [Abstract][Full Text] [Related]
34. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
[TBL] [Abstract][Full Text] [Related]
35. Isolation of ginkgolides A, B, C, J and bilobalide from G. biloba extracts.
Jaracz S; Malik S; Nakanishi K
Phytochemistry; 2004 Nov; 65(21):2897-902. PubMed ID: 15501258
[TBL] [Abstract][Full Text] [Related]
36. Transformation of multi-component ginkgolide into ginkgolide B by Coprinus comatus.
Ding H; Zhang Z; Cao S; Xu Y; Yu J
BMC Biotechnol; 2015 Mar; 15():17. PubMed ID: 25887229
[TBL] [Abstract][Full Text] [Related]
37. Modulation of CYP1A1 activity by a Ginkgo biloba extract in the human intestinal Caco-2 cells.
Ribonnet L; Callebaut A; Nobels I; Scippo ML; Schneider YJ; De Saeger S; Pussemier L; Larondelle Y
Toxicol Lett; 2011 May; 202(3):193-202. PubMed ID: 21329749
[TBL] [Abstract][Full Text] [Related]
38. Effects of ginkgo biloba extract on cation currents in rat ventricular myocytes.
Chen B; Cai J; Song LS; Wang X; Chen Z
Life Sci; 2005 Jan; 76(10):1111-21. PubMed ID: 15620575
[TBL] [Abstract][Full Text] [Related]
39. Spectroscopic investigation of Ginkgo biloba terpene trilactones and their interaction with amyloid peptide Abeta(25-35).
He J; Petrovic AG; Dzyuba SV; Berova N; Nakanishi K; Polavarapu PL
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1213-22. PubMed ID: 17693130
[TBL] [Abstract][Full Text] [Related]
40. Two new ginkgolides from the leaves of Ginkgo biloba.
Liao HJ; Zheng YF; Li HY; Peng GP
Planta Med; 2011 Nov; 77(16):1818-21. PubMed ID: 21614751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
